Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
tai-screen-luciferase | 6.242 | 1.24e-129 | 8.55e-07 | 3.77e-03 |
Gene Symbol | Entrez Gene ID | Frequency | tai-screen-luciferase gene score | Best subnetwork score | Degree | List-Gonzales GI | Tai-Hits |
---|---|---|---|---|---|---|---|
RPS20 | 6224 | 4 | -4.757 | 6.314 | 153 | Yes | - |
RPS15 | 6209 | 7 | -5.040 | 7.011 | 116 | Yes | - |
COPA | 1314 | 32 | -9.395 | 9.063 | 170 | Yes | Yes |
RPS29 | 6235 | 3 | -8.386 | 6.597 | 29 | - | - |
RPS24 | 6229 | 21 | -7.034 | 8.389 | 217 | Yes | - |
TUBA1C | 84790 | 1 | -4.660 | 6.242 | 91 | - | Yes |
PLA2G12A | 81579 | 1 | 2.326 | 6.242 | 9 | - | - |
RPS9 | 6203 | 18 | -7.127 | 7.555 | 140 | Yes | - |
COPB2 | 9276 | 32 | -13.168 | 9.063 | 41 | Yes | Yes |
RPS4X | 6191 | 18 | -6.747 | 7.555 | 263 | Yes | - |
ATG4C | 84938 | 1 | 2.130 | 6.242 | 321 | - | - |
COPZ1 | 22818 | 32 | -8.301 | 9.063 | 13 | Yes | Yes |
CDC42 | 998 | 11 | -6.960 | 8.389 | 265 | Yes | Yes |
RPS27A | 6233 | 15 | -5.631 | 8.389 | 342 | Yes | - |
RPS11 | 6205 | 17 | -6.588 | 7.555 | 175 | Yes | - |
RPS14 | 6208 | 4 | -4.803 | 7.011 | 191 | Yes | - |
RPS6 | 6194 | 17 | -5.603 | 8.046 | 208 | Yes | - |
[ UMPS ] | 7372 | 1 | 1.909 | 6.242 | 18 | - | - |
RPS26 | 6231 | 17 | -7.478 | 8.046 | 60 | Yes | - |
ARCN1 | 372 | 32 | -8.232 | 9.063 | 118 | Yes | Yes |
RPS23 | 6228 | 3 | -4.485 | 6.375 | 118 | Yes | - |
COPB1 | 1315 | 22 | -6.221 | 9.063 | 118 | Yes | Yes |
RPS13 | 6207 | 17 | -6.589 | 7.555 | 174 | Yes | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
RPS9 | 6203 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS11 | 6205 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS9 | 6203 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
RPS4X | 6191 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
CDC42 | 998 | RPS27A | 6233 | pp | -- | int.I2D: SOURAV_MAPK_HIGH |
RPS4X | 6191 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS23 | 6228 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
COPA | 1314 | COPB1 | 1315 | pp | -- | int.I2D: BioGrid, BioGrid_Yeast, BIND_Yeast, IntAct_Yeast, MINT_Yeast, Krogan_Core, YeastHigh |
RPS6 | 6194 | RPS23 | 6228 | pp | -- | int.I2D: YeastLow, BioGrid_Yeast |
RPS23 | 6228 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS9 | 6203 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
COPB1 | 1315 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS6 | 6194 | RPS20 | 6224 | pp | -- | int.I2D: YeastLow |
RPS13 | 6207 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
ARCN1 | 372 | COPA | 1314 | pp | -- | int.I2D: BCI, BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, YeastHigh, HPRD, Krogan_Core; int.HPRD: in vivo |
RPS14 | 6208 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS24 | 6229 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS4X | 6191 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
ARCN1 | 372 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, Tarassov_PCA, YeastMedium, INTEROLOG |
COPA | 1314 | COPB2 | 9276 | pp | -- | int.I2D: BioGrid, HPRD, BCI; int.HPRD: in vivo |
RPS15 | 6209 | RPS23 | 6228 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium |
RPS13 | 6207 | RPS15 | 6209 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
RPS6 | 6194 | PLA2G12A | 81579 | pp | -- | int.Intact: MI:0915(physical association) |
COPA | 1314 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastMedium |
RPS11 | 6205 | RPS15 | 6209 | pp | -- | int.I2D: INTEROLOG, YeastMedium |
RPS6 | 6194 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
RPS11 | 6205 | RPS20 | 6224 | pp | -- | int.I2D: YeastMedium, INTEROLOG |
RPS20 | 6224 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
UMPS | 7372 | PLA2G12A | 81579 | pp | -- | int.Intact: MI:0915(physical association) |
RPS15 | 6209 | PLA2G12A | 81579 | pp | -- | int.Intact: MI:0915(physical association) |
RPS4X | 6191 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium |
RPS4X | 6191 | RPS9 | 6203 | pp | -- | int.I2D: BioGrid_Yeast |
RPS20 | 6224 | RPS23 | 6228 | pp | -- | int.I2D: YeastMedium, INTEROLOG |
RPS6 | 6194 | RPS15 | 6209 | pp | -- | int.I2D: BioGrid_Yeast |
RPS13 | 6207 | RPS20 | 6224 | pp | -- | int.I2D: BioGrid_Yeast |
RPS20 | 6224 | RPS26 | 6231 | pp | -- | int.I2D: YeastLow |
RPS11 | 6205 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
RPS29 | 6235 | UMPS | 7372 | pp | -- | int.Intact: MI:0915(physical association) |
TUBA1C | 84790 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
ARCN1 | 372 | COPB1 | 1315 | pp | -- | int.I2D: BCI, BioGrid, BioGrid_Yeast, IntAct_Yeast, INTEROLOG, MINT_Yeast, YeastHigh, BIND, BIND_Yeast, HPRD, Krogan_Core, MIPS; int.HPRD: in vivo |
RPS6 | 6194 | RPS26 | 6231 | pp | -- | int.I2D: YeastLow |
COPA | 1314 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
RPS6 | 6194 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
RPS11 | 6205 | RPS13 | 6207 | pp | -- | int.I2D: BioGrid_Yeast |
UMPS | 7372 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS6 | 6194 | RPS11 | 6205 | pp | -- | int.I2D: BioGrid_Yeast |
RPS6 | 6194 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS4X | 6191 | RPS6 | 6194 | pp | -- | int.I2D: BioGrid_Yeast |
RPS14 | 6208 | RPS15 | 6209 | pp | -- | int.I2D: INTEROLOG, YeastMedium |
RPS15 | 6209 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS13 | 6207 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
ARCN1 | 372 | COPB2 | 9276 | pp | -- | int.I2D: HPRD, BCI; int.HPRD: in vivo |
RPS27A | 6233 | ATG4C | 84938 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
RPS20 | 6224 | RPS27A | 6233 | pp | -- | int.I2D: YeastLow |
RPS15 | 6209 | RPS20 | 6224 | pp | -- | int.I2D: BioGrid_Yeast, INTEROLOG, YeastMedium |
RPS14 | 6208 | RPS24 | 6229 | pp | -- | int.I2D: BioGrid_Yeast |
RPS4X | 6191 | RPS15 | 6209 | pp | -- | int.I2D: INTEROLOG, YeastMedium |
COPB1 | 1315 | COPB2 | 9276 | pp | -- | int.I2D: BioGrid |
RPS4X | 6191 | RPS14 | 6208 | pp | -- | int.I2D: BioGrid_Yeast |
RPS24 | 6229 | RPS27A | 6233 | pp | -- | int.I2D: YeastMedium |
RPS14 | 6208 | RPS20 | 6224 | pp | -- | int.I2D: INTEROLOG, YeastMedium, BioGrid_Yeast |
COPB1 | 1315 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, Tarassov_PCA, YeastMedium; int.DIP: MI:0915(physical association) |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0022627 | cytosolic small ribosomal subunit | 4.90e-29 | 7.06e-25 | 7.708 | 13 | 20 | 39 |
GO:0019083 | viral transcription | 2.20e-24 | 3.18e-20 | 6.653 | 13 | 20 | 81 |
GO:0006415 | translational termination | 5.98e-24 | 8.62e-20 | 6.550 | 13 | 20 | 87 |
GO:0006414 | translational elongation | 1.51e-23 | 2.18e-19 | 6.454 | 13 | 20 | 93 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 7.07e-23 | 1.02e-18 | 6.293 | 13 | 20 | 104 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2.49e-22 | 3.59e-18 | 6.160 | 13 | 20 | 114 |
GO:0019058 | viral life cycle | 2.80e-22 | 4.04e-18 | 6.147 | 13 | 23 | 115 |
GO:0006413 | translational initiation | 1.65e-21 | 2.38e-17 | 5.960 | 13 | 21 | 131 |
GO:0003735 | structural constituent of ribosome | 3.02e-21 | 4.36e-17 | 5.895 | 13 | 22 | 137 |
GO:0016071 | mRNA metabolic process | 2.03e-18 | 2.92e-14 | 5.192 | 13 | 25 | 223 |
GO:0006412 | translation | 3.05e-18 | 4.40e-14 | 5.147 | 13 | 23 | 230 |
GO:0016070 | RNA metabolic process | 7.81e-18 | 1.13e-13 | 5.045 | 13 | 25 | 247 |
GO:0044267 | cellular protein metabolic process | 8.85e-16 | 1.28e-11 | 4.211 | 14 | 23 | 474 |
GO:0016032 | viral process | 4.63e-15 | 6.67e-11 | 4.039 | 14 | 33 | 534 |
GO:0005829 | cytosol | 1.66e-14 | 2.39e-10 | 2.399 | 21 | 61 | 2496 |
GO:0015935 | small ribosomal subunit | 9.89e-14 | 1.43e-09 | 7.790 | 6 | 9 | 17 |
GO:0010467 | gene expression | 3.06e-12 | 4.41e-08 | 3.607 | 13 | 29 | 669 |
GO:0030126 | COPI vesicle coat | 5.09e-12 | 7.34e-08 | 8.029 | 5 | 7 | 12 |
GO:0048205 | COPI coating of Golgi vesicle | 8.26e-12 | 1.19e-07 | 7.914 | 5 | 8 | 13 |
GO:0016020 | membrane | 1.19e-10 | 1.72e-06 | 2.577 | 16 | 41 | 1681 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 3.37e-10 | 4.86e-06 | 6.971 | 5 | 8 | 25 |
GO:0044822 | poly(A) RNA binding | 9.26e-10 | 1.34e-05 | 2.949 | 13 | 32 | 1056 |
GO:0005840 | ribosome | 2.81e-08 | 4.05e-04 | 5.756 | 5 | 8 | 58 |
GO:0005925 | focal adhesion | 5.60e-08 | 8.07e-04 | 3.777 | 8 | 19 | 366 |
GO:0061024 | membrane organization | 8.16e-08 | 1.18e-03 | 4.698 | 6 | 12 | 145 |
GO:0042274 | ribosomal small subunit biogenesis | 7.72e-07 | 1.11e-02 | 7.293 | 3 | 6 | 12 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 2.37e-06 | 3.42e-02 | 6.790 | 3 | 4 | 17 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 5.35e-06 | 7.71e-02 | 6.418 | 3 | 3 | 22 |
GO:0006886 | intracellular protein transport | 6.25e-06 | 9.02e-02 | 4.197 | 5 | 7 | 171 |
GO:0019843 | rRNA binding | 1.01e-05 | 1.46e-01 | 6.123 | 3 | 4 | 27 |
GO:0033119 | negative regulation of RNA splicing | 2.43e-05 | 3.50e-01 | 7.971 | 2 | 2 | 5 |
GO:0045182 | translation regulator activity | 3.63e-05 | 5.24e-01 | 7.708 | 2 | 2 | 6 |
GO:0000028 | ribosomal small subunit assembly | 5.08e-05 | 7.33e-01 | 7.485 | 2 | 3 | 7 |
GO:0005198 | structural molecule activity | 8.53e-05 | 1.00e+00 | 4.064 | 4 | 6 | 150 |
GO:0006364 | rRNA processing | 4.32e-04 | 1.00e+00 | 4.323 | 3 | 7 | 94 |
GO:0070062 | extracellular vesicular exosome | 5.05e-04 | 1.00e+00 | 1.523 | 11 | 40 | 2400 |
GO:0005844 | polysome | 6.03e-04 | 1.00e+00 | 5.769 | 2 | 2 | 23 |
GO:0030529 | ribonucleoprotein complex | 7.21e-04 | 1.00e+00 | 4.070 | 3 | 7 | 112 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 1.48e-03 | 1.00e+00 | 5.123 | 2 | 3 | 36 |
GO:0022605 | oogenesis stage | 1.59e-03 | 1.00e+00 | 9.293 | 1 | 1 | 1 |
GO:0004588 | orotate phosphoribosyltransferase activity | 1.59e-03 | 1.00e+00 | 9.293 | 1 | 1 | 1 |
GO:0004590 | orotidine-5'-phosphate decarboxylase activity | 1.59e-03 | 1.00e+00 | 9.293 | 1 | 1 | 1 |
GO:0021691 | cerebellar Purkinje cell layer maturation | 1.59e-03 | 1.00e+00 | 9.293 | 1 | 1 | 1 |
GO:0005737 | cytoplasm | 1.91e-03 | 1.00e+00 | 1.114 | 13 | 43 | 3767 |
GO:0071338 | positive regulation of hair follicle cell proliferation | 3.19e-03 | 1.00e+00 | 8.293 | 1 | 1 | 2 |
GO:0060661 | submandibular salivary gland formation | 3.19e-03 | 1.00e+00 | 8.293 | 1 | 1 | 2 |
GO:0090135 | actin filament branching | 3.19e-03 | 1.00e+00 | 8.293 | 1 | 1 | 2 |
GO:0006417 | regulation of translation | 4.34e-03 | 1.00e+00 | 4.338 | 2 | 2 | 62 |
GO:0051683 | establishment of Golgi localization | 4.78e-03 | 1.00e+00 | 7.708 | 1 | 2 | 3 |
GO:0034191 | apolipoprotein A-I receptor binding | 4.78e-03 | 1.00e+00 | 7.708 | 1 | 1 | 3 |
GO:0003161 | cardiac conduction system development | 4.78e-03 | 1.00e+00 | 7.708 | 1 | 1 | 3 |
GO:0000056 | ribosomal small subunit export from nucleus | 4.78e-03 | 1.00e+00 | 7.708 | 1 | 2 | 3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 4.78e-03 | 1.00e+00 | 7.708 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 4.78e-03 | 1.00e+00 | 7.708 | 1 | 1 | 3 |
GO:0003729 | mRNA binding | 5.81e-03 | 1.00e+00 | 4.123 | 2 | 2 | 72 |
GO:0030490 | maturation of SSU-rRNA | 6.36e-03 | 1.00e+00 | 7.293 | 1 | 2 | 4 |
GO:0048664 | neuron fate determination | 6.36e-03 | 1.00e+00 | 7.293 | 1 | 1 | 4 |
GO:0060684 | epithelial-mesenchymal cell signaling | 6.36e-03 | 1.00e+00 | 7.293 | 1 | 1 | 4 |
GO:0051835 | positive regulation of synapse structural plasticity | 6.36e-03 | 1.00e+00 | 7.293 | 1 | 1 | 4 |
GO:0006222 | UMP biosynthetic process | 6.36e-03 | 1.00e+00 | 7.293 | 1 | 1 | 4 |
GO:0072384 | organelle transport along microtubule | 6.36e-03 | 1.00e+00 | 7.293 | 1 | 2 | 4 |
GO:0036336 | dendritic cell migration | 7.95e-03 | 1.00e+00 | 6.971 | 1 | 1 | 5 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 7.95e-03 | 1.00e+00 | 6.971 | 1 | 1 | 5 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 7.95e-03 | 1.00e+00 | 6.971 | 1 | 3 | 5 |
GO:0031256 | leading edge membrane | 7.95e-03 | 1.00e+00 | 6.971 | 1 | 1 | 5 |
GO:0001649 | osteoblast differentiation | 9.33e-03 | 1.00e+00 | 3.769 | 2 | 3 | 92 |
GO:0007097 | nuclear migration | 9.53e-03 | 1.00e+00 | 6.708 | 1 | 1 | 6 |
GO:0003334 | keratinocyte development | 9.53e-03 | 1.00e+00 | 6.708 | 1 | 1 | 6 |
GO:0002309 | T cell proliferation involved in immune response | 9.53e-03 | 1.00e+00 | 6.708 | 1 | 1 | 6 |
GO:0060789 | hair follicle placode formation | 9.53e-03 | 1.00e+00 | 6.708 | 1 | 1 | 6 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 9.53e-03 | 1.00e+00 | 6.708 | 1 | 1 | 6 |
GO:0048554 | positive regulation of metalloenzyme activity | 9.53e-03 | 1.00e+00 | 6.708 | 1 | 1 | 6 |
GO:0006924 | activation-induced cell death of T cells | 9.53e-03 | 1.00e+00 | 6.708 | 1 | 1 | 6 |
GO:0043497 | regulation of protein heterodimerization activity | 9.53e-03 | 1.00e+00 | 6.708 | 1 | 1 | 6 |
GO:0048027 | mRNA 5'-UTR binding | 1.11e-02 | 1.00e+00 | 6.485 | 1 | 1 | 7 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 1.11e-02 | 1.00e+00 | 6.485 | 1 | 1 | 7 |
GO:0034101 | erythrocyte homeostasis | 1.11e-02 | 1.00e+00 | 6.485 | 1 | 1 | 7 |
GO:0051489 | regulation of filopodium assembly | 1.11e-02 | 1.00e+00 | 6.485 | 1 | 1 | 7 |
GO:0047498 | calcium-dependent phospholipase A2 activity | 1.11e-02 | 1.00e+00 | 6.485 | 1 | 1 | 7 |
GO:0030157 | pancreatic juice secretion | 1.11e-02 | 1.00e+00 | 6.485 | 1 | 1 | 7 |
GO:0005730 | nucleolus | 1.15e-02 | 1.00e+00 | 1.420 | 7 | 24 | 1641 |
GO:0090136 | epithelial cell-cell adhesion | 1.43e-02 | 1.00e+00 | 6.123 | 1 | 1 | 9 |
GO:0036150 | phosphatidylserine acyl-chain remodeling | 1.43e-02 | 1.00e+00 | 6.123 | 1 | 1 | 9 |
GO:0031274 | positive regulation of pseudopodium assembly | 1.58e-02 | 1.00e+00 | 5.971 | 1 | 2 | 10 |
GO:0005798 | Golgi-associated vesicle | 1.58e-02 | 1.00e+00 | 5.971 | 1 | 1 | 10 |
GO:0060047 | heart contraction | 1.58e-02 | 1.00e+00 | 5.971 | 1 | 1 | 10 |
GO:0036149 | phosphatidylinositol acyl-chain remodeling | 1.74e-02 | 1.00e+00 | 5.833 | 1 | 1 | 11 |
GO:0036148 | phosphatidylglycerol acyl-chain remodeling | 1.90e-02 | 1.00e+00 | 5.708 | 1 | 1 | 12 |
GO:0019082 | viral protein processing | 1.90e-02 | 1.00e+00 | 5.708 | 1 | 2 | 12 |
GO:0031929 | TOR signaling | 2.05e-02 | 1.00e+00 | 5.592 | 1 | 1 | 13 |
GO:0032479 | regulation of type I interferon production | 2.05e-02 | 1.00e+00 | 5.592 | 1 | 2 | 13 |
GO:0031333 | negative regulation of protein complex assembly | 2.21e-02 | 1.00e+00 | 5.485 | 1 | 1 | 14 |
GO:0030705 | cytoskeleton-dependent intracellular transport | 2.21e-02 | 1.00e+00 | 5.485 | 1 | 1 | 14 |
GO:0031996 | thioesterase binding | 2.21e-02 | 1.00e+00 | 5.485 | 1 | 1 | 14 |
GO:0030131 | clathrin adaptor complex | 2.21e-02 | 1.00e+00 | 5.485 | 1 | 2 | 14 |
GO:0036152 | phosphatidylethanolamine acyl-chain remodeling | 2.21e-02 | 1.00e+00 | 5.485 | 1 | 1 | 14 |
GO:0000082 | G1/S transition of mitotic cell cycle | 2.33e-02 | 1.00e+00 | 3.073 | 2 | 9 | 149 |
GO:0048821 | erythrocyte development | 2.37e-02 | 1.00e+00 | 5.386 | 1 | 1 | 15 |
GO:0030225 | macrophage differentiation | 2.37e-02 | 1.00e+00 | 5.386 | 1 | 1 | 15 |
GO:0031369 | translation initiation factor binding | 2.37e-02 | 1.00e+00 | 5.386 | 1 | 1 | 15 |
GO:0051233 | spindle midzone | 2.37e-02 | 1.00e+00 | 5.386 | 1 | 2 | 15 |
GO:0042176 | regulation of protein catabolic process | 2.52e-02 | 1.00e+00 | 5.293 | 1 | 3 | 16 |
GO:0075733 | intracellular transport of virus | 2.68e-02 | 1.00e+00 | 5.205 | 1 | 3 | 17 |
GO:0030742 | GTP-dependent protein binding | 2.68e-02 | 1.00e+00 | 5.205 | 1 | 1 | 17 |
GO:0019068 | virion assembly | 2.68e-02 | 1.00e+00 | 5.205 | 1 | 2 | 17 |
GO:0090316 | positive regulation of intracellular protein transport | 2.68e-02 | 1.00e+00 | 5.205 | 1 | 1 | 17 |
GO:0006612 | protein targeting to membrane | 2.83e-02 | 1.00e+00 | 5.123 | 1 | 1 | 18 |
GO:0007088 | regulation of mitosis | 2.83e-02 | 1.00e+00 | 5.123 | 1 | 1 | 18 |
GO:0036151 | phosphatidylcholine acyl-chain remodeling | 2.83e-02 | 1.00e+00 | 5.123 | 1 | 1 | 18 |
GO:0046847 | filopodium assembly | 2.99e-02 | 1.00e+00 | 5.045 | 1 | 1 | 19 |
GO:0007369 | gastrulation | 2.99e-02 | 1.00e+00 | 5.045 | 1 | 1 | 19 |
GO:0043473 | pigmentation | 3.14e-02 | 1.00e+00 | 4.971 | 1 | 1 | 20 |
GO:0006654 | phosphatidic acid biosynthetic process | 3.30e-02 | 1.00e+00 | 4.900 | 1 | 1 | 21 |
GO:0031435 | mitogen-activated protein kinase kinase kinase binding | 3.30e-02 | 1.00e+00 | 4.900 | 1 | 1 | 21 |
GO:0031424 | keratinization | 3.45e-02 | 1.00e+00 | 4.833 | 1 | 1 | 22 |
GO:0007220 | Notch receptor processing | 3.45e-02 | 1.00e+00 | 4.833 | 1 | 2 | 22 |
GO:0006206 | pyrimidine nucleobase metabolic process | 3.45e-02 | 1.00e+00 | 4.833 | 1 | 1 | 22 |
GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading | 3.61e-02 | 1.00e+00 | 4.769 | 1 | 1 | 23 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 3.61e-02 | 1.00e+00 | 2.730 | 2 | 4 | 189 |
GO:0002040 | sprouting angiogenesis | 3.61e-02 | 1.00e+00 | 4.769 | 1 | 1 | 23 |
GO:0051017 | actin filament bundle assembly | 3.61e-02 | 1.00e+00 | 4.769 | 1 | 1 | 23 |
GO:0007163 | establishment or maintenance of cell polarity | 3.76e-02 | 1.00e+00 | 4.708 | 1 | 1 | 24 |
GO:0003924 | GTPase activity | 3.89e-02 | 1.00e+00 | 2.670 | 2 | 7 | 197 |
GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | 3.91e-02 | 1.00e+00 | 4.649 | 1 | 2 | 25 |
GO:0005978 | glycogen biosynthetic process | 4.07e-02 | 1.00e+00 | 4.592 | 1 | 2 | 26 |
GO:0000045 | autophagic vacuole assembly | 4.07e-02 | 1.00e+00 | 4.592 | 1 | 1 | 26 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 4.07e-02 | 1.00e+00 | 4.592 | 1 | 2 | 26 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 4.07e-02 | 1.00e+00 | 4.592 | 1 | 2 | 26 |
GO:0045859 | regulation of protein kinase activity | 4.07e-02 | 1.00e+00 | 4.592 | 1 | 1 | 26 |
GO:0051149 | positive regulation of muscle cell differentiation | 4.22e-02 | 1.00e+00 | 4.538 | 1 | 1 | 27 |
GO:0032467 | positive regulation of cytokinesis | 4.22e-02 | 1.00e+00 | 4.538 | 1 | 1 | 27 |
GO:0007017 | microtubule-based process | 4.22e-02 | 1.00e+00 | 4.538 | 1 | 1 | 27 |
GO:0051258 | protein polymerization | 4.22e-02 | 1.00e+00 | 4.538 | 1 | 1 | 27 |
GO:0031069 | hair follicle morphogenesis | 4.22e-02 | 1.00e+00 | 4.538 | 1 | 1 | 27 |
GO:0006184 | GTP catabolic process | 4.52e-02 | 1.00e+00 | 2.551 | 2 | 7 | 214 |
GO:0072686 | mitotic spindle | 4.53e-02 | 1.00e+00 | 4.435 | 1 | 1 | 29 |
GO:0031647 | regulation of protein stability | 4.68e-02 | 1.00e+00 | 4.386 | 1 | 1 | 30 |
GO:0001890 | placenta development | 4.83e-02 | 1.00e+00 | 4.338 | 1 | 1 | 31 |
GO:0007093 | mitotic cell cycle checkpoint | 4.83e-02 | 1.00e+00 | 4.338 | 1 | 1 | 31 |
GO:0032480 | negative regulation of type I interferon production | 4.98e-02 | 1.00e+00 | 4.293 | 1 | 2 | 32 |
GO:0033077 | T cell differentiation in thymus | 5.14e-02 | 1.00e+00 | 4.248 | 1 | 1 | 33 |
GO:0042692 | muscle cell differentiation | 5.29e-02 | 1.00e+00 | 4.205 | 1 | 1 | 34 |
GO:0034332 | adherens junction organization | 5.59e-02 | 1.00e+00 | 4.123 | 1 | 2 | 36 |
GO:0045740 | positive regulation of DNA replication | 5.59e-02 | 1.00e+00 | 4.123 | 1 | 1 | 36 |
GO:0051084 | 'de novo' posttranslational protein folding | 5.74e-02 | 1.00e+00 | 4.083 | 1 | 1 | 37 |
GO:0030218 | erythrocyte differentiation | 5.74e-02 | 1.00e+00 | 4.083 | 1 | 2 | 37 |
GO:0007595 | lactation | 6.04e-02 | 1.00e+00 | 4.007 | 1 | 1 | 39 |
GO:0005881 | cytoplasmic microtubule | 6.19e-02 | 1.00e+00 | 3.971 | 1 | 1 | 40 |
GO:0007249 | I-kappaB kinase/NF-kappaB signaling | 6.34e-02 | 1.00e+00 | 3.935 | 1 | 3 | 41 |
GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 6.64e-02 | 1.00e+00 | 3.866 | 1 | 2 | 43 |
GO:0043065 | positive regulation of apoptotic process | 6.74e-02 | 1.00e+00 | 2.226 | 2 | 6 | 268 |
GO:0021762 | substantia nigra development | 6.79e-02 | 1.00e+00 | 3.833 | 1 | 1 | 44 |
GO:0034613 | cellular protein localization | 6.79e-02 | 1.00e+00 | 3.833 | 1 | 2 | 44 |
GO:0045727 | positive regulation of translation | 6.79e-02 | 1.00e+00 | 3.833 | 1 | 1 | 44 |
GO:0008344 | adult locomotory behavior | 6.79e-02 | 1.00e+00 | 3.833 | 1 | 1 | 44 |
GO:0044297 | cell body | 7.09e-02 | 1.00e+00 | 3.769 | 1 | 1 | 46 |
GO:0043525 | positive regulation of neuron apoptotic process | 7.09e-02 | 1.00e+00 | 3.769 | 1 | 2 | 46 |
GO:0005794 | Golgi apparatus | 7.12e-02 | 1.00e+00 | 1.625 | 3 | 9 | 610 |
GO:0016042 | lipid catabolic process | 7.39e-02 | 1.00e+00 | 3.708 | 1 | 1 | 48 |
GO:0007030 | Golgi organization | 7.53e-02 | 1.00e+00 | 3.678 | 1 | 2 | 49 |
GO:0007254 | JNK cascade | 7.53e-02 | 1.00e+00 | 3.678 | 1 | 3 | 49 |
GO:0035690 | cellular response to drug | 7.53e-02 | 1.00e+00 | 3.678 | 1 | 2 | 49 |
GO:0030175 | filopodium | 7.68e-02 | 1.00e+00 | 3.649 | 1 | 2 | 50 |
GO:0004197 | cysteine-type endopeptidase activity | 7.68e-02 | 1.00e+00 | 3.649 | 1 | 1 | 50 |
GO:0030666 | endocytic vesicle membrane | 8.12e-02 | 1.00e+00 | 3.565 | 1 | 2 | 53 |
GO:0008233 | peptidase activity | 8.27e-02 | 1.00e+00 | 3.538 | 1 | 1 | 54 |
GO:0051403 | stress-activated MAPK cascade | 8.27e-02 | 1.00e+00 | 3.538 | 1 | 3 | 54 |
GO:0046330 | positive regulation of JNK cascade | 8.42e-02 | 1.00e+00 | 3.511 | 1 | 1 | 55 |
GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment | 8.57e-02 | 1.00e+00 | 3.485 | 1 | 1 | 56 |
GO:0005525 | GTP binding | 8.67e-02 | 1.00e+00 | 2.016 | 2 | 7 | 310 |
GO:0016197 | endosomal transport | 8.71e-02 | 1.00e+00 | 3.460 | 1 | 3 | 57 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 9.00e-02 | 1.00e+00 | 3.410 | 1 | 1 | 59 |
GO:0019901 | protein kinase binding | 9.00e-02 | 1.00e+00 | 1.984 | 2 | 6 | 317 |
GO:0043231 | intracellular membrane-bounded organelle | 9.05e-02 | 1.00e+00 | 1.980 | 2 | 5 | 318 |
GO:0032481 | positive regulation of type I interferon production | 9.29e-02 | 1.00e+00 | 3.362 | 1 | 3 | 61 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 9.29e-02 | 1.00e+00 | 3.362 | 1 | 2 | 61 |
GO:0030141 | secretory granule | 9.44e-02 | 1.00e+00 | 3.338 | 1 | 1 | 62 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 9.73e-02 | 1.00e+00 | 3.293 | 1 | 6 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 9.87e-02 | 1.00e+00 | 3.270 | 1 | 6 | 65 |
GO:0031295 | T cell costimulation | 9.87e-02 | 1.00e+00 | 3.270 | 1 | 3 | 65 |
GO:0034166 | toll-like receptor 10 signaling pathway | 9.87e-02 | 1.00e+00 | 3.270 | 1 | 4 | 65 |
GO:0034146 | toll-like receptor 5 signaling pathway | 9.87e-02 | 1.00e+00 | 3.270 | 1 | 4 | 65 |
GO:0035264 | multicellular organism growth | 1.02e-01 | 1.00e+00 | 3.226 | 1 | 1 | 67 |
GO:0046474 | glycerophospholipid biosynthetic process | 1.06e-01 | 1.00e+00 | 3.163 | 1 | 2 | 70 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 1.06e-01 | 1.00e+00 | 3.163 | 1 | 2 | 70 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.06e-01 | 1.00e+00 | 3.163 | 1 | 8 | 70 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 1.07e-01 | 1.00e+00 | 3.143 | 1 | 4 | 71 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 1.07e-01 | 1.00e+00 | 3.143 | 1 | 4 | 71 |
GO:0034162 | toll-like receptor 9 signaling pathway | 1.09e-01 | 1.00e+00 | 3.123 | 1 | 4 | 72 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 1.09e-01 | 1.00e+00 | 3.123 | 1 | 6 | 72 |
GO:0034134 | toll-like receptor 2 signaling pathway | 1.10e-01 | 1.00e+00 | 3.103 | 1 | 4 | 73 |
GO:0006914 | autophagy | 1.12e-01 | 1.00e+00 | 3.083 | 1 | 1 | 74 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 1.12e-01 | 1.00e+00 | 3.083 | 1 | 2 | 74 |
GO:0000139 | Golgi membrane | 1.12e-01 | 1.00e+00 | 1.797 | 2 | 6 | 361 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.12e-01 | 1.00e+00 | 3.083 | 1 | 8 | 74 |
GO:0060070 | canonical Wnt signaling pathway | 1.13e-01 | 1.00e+00 | 3.064 | 1 | 1 | 75 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 1.13e-01 | 1.00e+00 | 3.064 | 1 | 6 | 75 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 1.15e-01 | 1.00e+00 | 3.045 | 1 | 4 | 76 |
GO:0010629 | negative regulation of gene expression | 1.16e-01 | 1.00e+00 | 3.026 | 1 | 2 | 77 |
GO:0007565 | female pregnancy | 1.17e-01 | 1.00e+00 | 3.007 | 1 | 1 | 78 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 1.17e-01 | 1.00e+00 | 3.007 | 1 | 4 | 78 |
GO:0034138 | toll-like receptor 3 signaling pathway | 1.19e-01 | 1.00e+00 | 2.989 | 1 | 4 | 79 |
GO:0005179 | hormone activity | 1.19e-01 | 1.00e+00 | 2.989 | 1 | 1 | 79 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.19e-01 | 1.00e+00 | 2.989 | 1 | 8 | 79 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 1.20e-01 | 1.00e+00 | 2.971 | 1 | 4 | 80 |
GO:0045177 | apical part of cell | 1.22e-01 | 1.00e+00 | 2.953 | 1 | 1 | 81 |
GO:0051301 | cell division | 1.22e-01 | 1.00e+00 | 2.953 | 1 | 2 | 81 |
GO:0008284 | positive regulation of cell proliferation | 1.23e-01 | 1.00e+00 | 1.715 | 2 | 7 | 382 |
GO:0050852 | T cell receptor signaling pathway | 1.27e-01 | 1.00e+00 | 2.883 | 1 | 2 | 85 |
GO:0042593 | glucose homeostasis | 1.30e-01 | 1.00e+00 | 2.850 | 1 | 1 | 87 |
GO:0000187 | activation of MAPK activity | 1.34e-01 | 1.00e+00 | 2.801 | 1 | 2 | 90 |
GO:0005200 | structural constituent of cytoskeleton | 1.36e-01 | 1.00e+00 | 2.785 | 1 | 3 | 91 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 1.37e-01 | 1.00e+00 | 2.769 | 1 | 6 | 92 |
GO:0071456 | cellular response to hypoxia | 1.37e-01 | 1.00e+00 | 2.769 | 1 | 3 | 92 |
GO:0034142 | toll-like receptor 4 signaling pathway | 1.42e-01 | 1.00e+00 | 2.708 | 1 | 4 | 96 |
GO:0043066 | negative regulation of apoptotic process | 1.46e-01 | 1.00e+00 | 1.565 | 2 | 13 | 424 |
GO:0030496 | midbody | 1.59e-01 | 1.00e+00 | 2.538 | 1 | 2 | 108 |
GO:0002224 | toll-like receptor signaling pathway | 1.60e-01 | 1.00e+00 | 2.524 | 1 | 4 | 109 |
GO:0005815 | microtubule organizing center | 1.60e-01 | 1.00e+00 | 2.524 | 1 | 3 | 109 |
GO:0097190 | apoptotic signaling pathway | 1.66e-01 | 1.00e+00 | 2.472 | 1 | 3 | 113 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 1.68e-01 | 1.00e+00 | 2.447 | 1 | 4 | 115 |
GO:0000209 | protein polyubiquitination | 1.70e-01 | 1.00e+00 | 2.435 | 1 | 7 | 116 |
GO:0006006 | glucose metabolic process | 1.72e-01 | 1.00e+00 | 2.410 | 1 | 3 | 118 |
GO:0007219 | Notch signaling pathway | 1.75e-01 | 1.00e+00 | 2.386 | 1 | 3 | 120 |
GO:0030036 | actin cytoskeleton organization | 1.79e-01 | 1.00e+00 | 2.350 | 1 | 2 | 123 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 1.80e-01 | 1.00e+00 | 2.338 | 1 | 3 | 124 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 1.86e-01 | 1.00e+00 | 2.293 | 1 | 3 | 128 |
GO:0006644 | phospholipid metabolic process | 1.87e-01 | 1.00e+00 | 2.281 | 1 | 3 | 129 |
GO:0031982 | vesicle | 1.89e-01 | 1.00e+00 | 2.259 | 1 | 1 | 131 |
GO:0005911 | cell-cell junction | 1.96e-01 | 1.00e+00 | 2.205 | 1 | 2 | 136 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.96e-01 | 1.00e+00 | 2.205 | 1 | 5 | 136 |
GO:0008286 | insulin receptor signaling pathway | 2.04e-01 | 1.00e+00 | 2.143 | 1 | 3 | 142 |
GO:0006457 | protein folding | 2.05e-01 | 1.00e+00 | 2.133 | 1 | 2 | 143 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 2.08e-01 | 1.00e+00 | 2.113 | 1 | 3 | 145 |
GO:0010628 | positive regulation of gene expression | 2.09e-01 | 1.00e+00 | 2.103 | 1 | 4 | 146 |
GO:0034220 | ion transmembrane transport | 2.13e-01 | 1.00e+00 | 2.073 | 1 | 2 | 149 |
GO:0042981 | regulation of apoptotic process | 2.14e-01 | 1.00e+00 | 2.064 | 1 | 7 | 150 |
GO:0010008 | endosome membrane | 2.15e-01 | 1.00e+00 | 2.054 | 1 | 5 | 151 |
GO:0008543 | fibroblast growth factor receptor signaling pathway | 2.21e-01 | 1.00e+00 | 2.007 | 1 | 3 | 156 |
GO:0005783 | endoplasmic reticulum | 2.22e-01 | 1.00e+00 | 1.174 | 2 | 3 | 556 |
GO:0043005 | neuron projection | 2.23e-01 | 1.00e+00 | 1.998 | 1 | 6 | 157 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 2.30e-01 | 1.00e+00 | 1.138 | 2 | 7 | 570 |
GO:0038095 | Fc-epsilon receptor signaling pathway | 2.36e-01 | 1.00e+00 | 1.900 | 1 | 3 | 168 |
GO:0045087 | innate immune response | 2.46e-01 | 1.00e+00 | 1.073 | 2 | 8 | 596 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 2.56e-01 | 1.00e+00 | 1.769 | 1 | 3 | 184 |
GO:0019221 | cytokine-mediated signaling pathway | 2.99e-01 | 1.00e+00 | 1.505 | 1 | 2 | 221 |
GO:0044281 | small molecule metabolic process | 3.04e-01 | 1.00e+00 | 0.636 | 3 | 15 | 1211 |
GO:0007067 | mitotic nuclear division | 3.06e-01 | 1.00e+00 | 1.466 | 1 | 5 | 227 |
GO:0030425 | dendrite | 3.09e-01 | 1.00e+00 | 1.447 | 1 | 2 | 230 |
GO:0043025 | neuronal cell body | 3.26e-01 | 1.00e+00 | 1.356 | 1 | 4 | 245 |
GO:0005874 | microtubule | 3.30e-01 | 1.00e+00 | 1.333 | 1 | 1 | 249 |
GO:0005975 | carbohydrate metabolic process | 3.35e-01 | 1.00e+00 | 1.310 | 1 | 3 | 253 |
GO:0000166 | nucleotide binding | 3.41e-01 | 1.00e+00 | 1.276 | 1 | 2 | 259 |
GO:0006281 | DNA repair | 3.43e-01 | 1.00e+00 | 1.265 | 1 | 4 | 261 |
GO:0005515 | protein binding | 3.49e-01 | 1.00e+00 | 0.195 | 11 | 62 | 6024 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 3.52e-01 | 1.00e+00 | 1.221 | 1 | 4 | 269 |
GO:0007264 | small GTPase mediated signal transduction | 3.62e-01 | 1.00e+00 | 1.168 | 1 | 7 | 279 |
GO:0007275 | multicellular organismal development | 3.99e-01 | 1.00e+00 | 0.989 | 1 | 1 | 316 |
GO:0007411 | axon guidance | 4.02e-01 | 1.00e+00 | 0.975 | 1 | 3 | 319 |
GO:0003723 | RNA binding | 4.24e-01 | 1.00e+00 | 0.875 | 1 | 8 | 342 |
GO:0005576 | extracellular region | 4.49e-01 | 1.00e+00 | 0.413 | 2 | 3 | 942 |
GO:0006508 | proteolysis | 4.57e-01 | 1.00e+00 | 0.730 | 1 | 1 | 378 |
GO:0008150 | biological_process | 4.67e-01 | 1.00e+00 | 0.689 | 1 | 3 | 389 |
GO:0000278 | mitotic cell cycle | 4.69e-01 | 1.00e+00 | 0.681 | 1 | 11 | 391 |
GO:0055085 | transmembrane transport | 5.06e-01 | 1.00e+00 | 0.528 | 1 | 3 | 435 |
GO:0007596 | blood coagulation | 5.22e-01 | 1.00e+00 | 0.463 | 1 | 3 | 455 |
GO:0005654 | nucleoplasm | 5.23e-01 | 1.00e+00 | 0.213 | 2 | 15 | 1082 |
GO:0042802 | identical protein binding | 5.44e-01 | 1.00e+00 | 0.374 | 1 | 3 | 484 |
GO:0048471 | perinuclear region of cytoplasm | 5.58e-01 | 1.00e+00 | 0.321 | 1 | 7 | 502 |
GO:0005509 | calcium ion binding | 5.78e-01 | 1.00e+00 | 0.240 | 1 | 2 | 531 |
GO:0006915 | apoptotic process | 5.95e-01 | 1.00e+00 | 0.176 | 1 | 9 | 555 |
GO:0005634 | nucleus | 6.25e-01 | 1.00e+00 | -0.055 | 7 | 43 | 4559 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 7.26e-01 | 1.00e+00 | -0.331 | 1 | 6 | 789 |
GO:0005615 | extracellular space | 7.94e-01 | 1.00e+00 | -0.610 | 1 | 2 | 957 |
GO:0005886 | plasma membrane | 8.07e-01 | 1.00e+00 | -0.457 | 3 | 20 | 2582 |
GO:0008270 | zinc ion binding | 8.08e-01 | 1.00e+00 | -0.669 | 1 | 3 | 997 |
GO:0005739 | mitochondrion | 8.08e-01 | 1.00e+00 | -0.670 | 1 | 8 | 998 |
GO:0003677 | DNA binding | 8.69e-01 | 1.00e+00 | -0.958 | 1 | 3 | 1218 |
GO:0046872 | metal ion binding | 8.88e-01 | 1.00e+00 | -1.060 | 1 | 10 | 1307 |
GO:0006351 | transcription, DNA-templated | 9.12e-01 | 1.00e+00 | -1.205 | 1 | 6 | 1446 |